Recently, Coloplast released a very satisfying full year result and a long term ambition of performing in line with the best med-tech companies.
The ambition is to be fulfilled by developing even better products; and better products made in a responsible way. An example is the catheter series SpeediCath® Compact and the urine bag series SpeediBag® Compact which is free of PVC and phthalates.
“Acting responsibly is one of our core values, but it also helps us drive growth. Since we published our first Corporate Responsibility Report in March 2010, we’ve experienced an increased interest in the topic – from investors, healthcare professionals and buyers. It shows how closely our corporate responsibility activities are linked to our business,” says Jeppe Kromann Haarsted, Corporate Responsibility Manager.
Within the same financial year, the company has among other improvements reduced the number of injuries and minimised waste and CO2 emission per unit produced.
Selected facts from the report
Coloplast can offer phthalate free alternatives to 80% of our products containing classified phthalates. In 2008/09 the number was 60%. The goal is 100% in 2011.
Reduction of greenhouse gas emission by 3.3% per unit produced, and 6% less waste in 2009/10 compared to last year.
Injury rates have fallen by more than 50% over the last four years.
Eight ‘Access to Healthcare’ projects approved in developing countries with a budget of DKK 6.8 million. 38% of managers in Coloplast are women.
Employee satisfaction rate has increased within engagement, values and well-being. 92% of all employees responded. Coloplast’s Corporate Responsibility Report covers the entire financial year and follows the international standard Global Reporting Initiative (GRI).
In 2002 Coloplast signed the UN Global Compact declaration and has since then been a member of the Dow Jones sustainability index and the FTSE4Good index.